LSX Nordic Congress | Biotech Leaders

Biotech Leaders is part of LSX Nordics

For the last 9 years, Biotech Leaders has been working with international life science & healthcare decision makers who are leading the next wave of industry innovation.

Our mission is to help them overcome challenges by connecting them with advisors and strategic partners that can help take their innovation from concept to market.

At the heart of the Biotech Leaders network are the founders and CEOs of the world’s most innovative drug discovery and therapeutic start-ups and SMEs.

They are joined by leading health and life science investors from across the Nordics and pharma who are on the look out for new innovation, partners and advisors.

Keld Flintholm Jørgensen

EVP & CBO, Lundbeck

Christof Bischoff

Country Director, Denmark, AstraZeneca

Nathalie ter Wengel

European Lead Worldwide Business Development, Pfizer

Jennifer Laird

VP, Search & Evaluation, Eli Lilly

Zaki Salanti

Senior Director Head of S&E, Novo Nordisk

Carsten Borring

Head of Listings & Capital Markets, Nasdaq Copenhagen

Henrijette-Richter--Managing-Partner--Sofinnova-ConvertImage

Henrijette Richer

Managing Partner, Sofinnova Partners

Renée Aguiar-Lucander

CEO, Calliditas Therapeutics

Claudio Costa

Operating Partner, Jeito Capital

Nanna Lüneborg

General Partner, Forbion

Hans Schambye

CEO, Galecto

Dennis Pedersen

CHRO & EVP, LEO Pharma

Claus Andersson

General Partner, Sunstone Ventures

Henrik Stage

Co-founder & CEO, Fuse Vectors

Camilla Petrycer Hansen, Principal Seed Investments, Novo Holdings

Sören Moller

Managing Partner, Novo Seeds

Jeroen Bakker

Principal Seed Investment, Novo Holdings

5 reasons to choose Biotech Leaders

LSX World Biotech Key Reasons 01

Biotech Leaders @ LSX Nordic Congress is the Nordic's largest and most significant Biotech CEO gathering. No other event is exclusively designed to address all the strategic and partnering goals of the Nordic Biotech CEO ecosystem.

LSX World Biotech Key Reasons 02

Biotech Leaders @ LSX Nordic Congress attracts the highest quality speakers from the biggest and best large pharma and life science investment firms. Hear from global BD heads at Lundbeck, AstraZeneca, Pfizer and Eli Lilly.

LSX World Biotech Key Reasons 03

No other event offers access to as many highly-qualified, specialist life science investors. LSX Nordic Congress will be bringing over 150 of the world’s most active investors to Denmark. Fundraising? There’s no better place to be.

LSX World Biotech Key Reasons 04

All biotechs, investors and pharma attendees are qualified during the registration process to ascertain their stage of development, strategic goals, therapeutic preferences, and fundraising/allocation targets. This provides absolute clarity on the issues that matter most to our attendees and allows delegates and partners to identify and target the most qualified prospects through our highly sophisticated 1-2-1 partnering system.

LSX World Biotech Key Reasons 05

As well as partnering, content, showcases and exhibition, Biotech Leaders @ LSX Nordic Congress offers a range of smaller group meetings, CEO forums targeting particular profiles of attendees. This means highly qualified groups of attendees to meet in an interactive and intimate setting and provides you with the opportunity to talk to the people that matter most to you.

Meet our speakers - Lundbeck, AZ, Pfizer, Eli Lilly & more!